Exceptional growth for Venture Capital Deals in radiopharmaceutical companies in 2023

<< Back to the news list

Exceptional growth for Venture Capital Deals in radiopharmaceutical companies in 2023

8 Dec 2023 | Misc, Radiopharmaceutical Therapy

GlobalData Reports that Venture Capital Deals in radiopharmaceutical companies have grown 550% to $408m in 2023

GlobalData reports that venture capital deals in radiopharmaceuticals have grown by 550% this year totalling $408m. It was only back in 2017 when the level of financing from venture capital in the field was only $63m. It is becoming increasingly clear that radiotherapeutics represents a further exciting modality to help with the battle against cancer.

https://www.globaldata.com/media/business-fundamentals/radiopharmaceutical-focused-vc-deals-in-us-see-staggering-550-growth-to-408-million-in-2023-reveals-globaldata/